Bristol-Myers Squibb Co’s recent filing unveils that its EVP, Chief Financial Officer Elkins David V unloaded Company’s shares for reported $2.65 million on Sep 02 ’25. In the deal valued at $47.33 per share,56,000 shares were sold. As a result of this transaction, Elkins David V now holds 167,379 shares worth roughly $7.76 million.
Then, Elkins David V bought 56,000 shares, generating $2,648,800 in total proceeds.
Before that, Short Bartie Wendy sold 378 shares. Bristol-Myers Squibb Co shares valued at $16,719 were divested by the EVP, Corporate Affairs at a price of $44.23 per share. As a result of the transaction, Short Bartie Wendy now holds 5,066 shares, worth roughly $0.23 million.
Daiwa Securities downgraded its Bristol-Myers Squibb Co [BMY] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Cantor Fitzgerald began covering BMY with “Neutral” recommendation on April 22, 2025. Jefferies revised its rating on December 16, 2024. It rated BMY as “a Buy” which previously was an “a Hold”.
Price Performance Review of BMY
On Tuesday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock fall -0.02% to $46.34. Over the last five days, the stock has lost -1.88%. Bristol-Myers Squibb Co shares have fallen nearly -3.94% since the year began. Nevertheless, the stocks have fallen -18.07% over the past one year.
How much short interest is there in Bristol-Myers Squibb Co?
A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-08-29, growing by 0.27 million shares to a total of 31.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 30.92 million shares. There was a rise of 0.88%, which implies that there is a positive sentiment for the stock.
